Swipe om te navigeren naar een ander artikel
Treatment-related symptom burden varies significantly among patients undergoing radiotherapy or chemoradiotherapy, yet such variation is typically not reflected in the results from single-group studies. We applied group-based trajectory modeling (GBTM) to describe the heterogeneity of symptom burden among patients with head and neck cancer and to identify subgroups with distinct symptom-development trajectories.
Patients (n = 130) were recruited pretherapy and rated multiple symptoms weekly for 10 weeks via the M. D. Anderson Symptom Inventory. With the mean of five most severe symptoms over time as an outcome measure, GBTM was used to identify patient subgroups with distinct symptom trajectories. Linear mixed-effects modeling (LMM) was applied to compare with GBTM’s ability to describe the longitudinal symptom data.
The five most severe symptoms were problems with taste, difficulty swallowing or chewing, problems with mucus, fatigue, and dry mouth. A two-group GBTM model identified 68 % of patients as having high symptom burden, associated with older age, worse baseline performance status, and chemoradiotherapy treatment. A four-group GBTM model generated one stable group (4 % of patients) and three groups varying in symptom severity with both linear and quadratic functions over time. LMM revealed symptom-change patterns similar to that produced by GBTM but was inferior in identifying risk factors for high symptom burden.
For cancer patients undergoing aggressive therapy, GBTM is capable of identifying various symptom-burden trajectories and provides severity groupings that will aid research and may be of clinical utility. These results may be generalizable to other cancer types and treatments.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Rosenthal, D. I., Mendoza, T., & Cleeland, C. (2009). Identifying head and neck patients at risk for high symptom burden during treatment [abstract]. American society of clinical oncology 2009 annual meeting, Orlando, FL, May 29–Jun 2, 2009. Journal of Clinical Oncology, 27(15 Suppl). Abstract #6066.
Dodd, M. J., Cho, M. H., Cooper, B. A., Petersen, J., Bank, K. A., Lee, K. A., et al. (2011). Identification of latent classes in patients who are receiving biotherapy based on symptom experience and its effect on functional status and quality of life. Oncology Nursing Forum, 38(1), 33–42. PubMedCrossRef
Merriman, J. D., Jansen, C., Koetters, T., West, C., Dodd, M., Lee, K., et al. (2010). Predictors of the trajectories of self-reported attentional fatigue in women with breast cancer undergoing radiation therapy. Oncology Nursing Society, 37(4), 423–432.
Klepstad, P., Dale, O., Kaasa, S., Zahlsen, K., Aamo, T., Fayers, P., et al. (2003). Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients. Acta Anaesthesiologica Scandinavica, 47(6), 725–731. PubMedCrossRef
Nagin, D. S. (2005). Group-based modeling of development. Cambridge, MA: Harvard University Press.
Modi, A. C., Cassedy, A. E., Quittner, A. L., Accurso, F., Sontag, M., Koenig, J. M., et al. (2010). Trajectories of adherence to airway clearance therapy for patients with cystic fibrosis. Journal of Pediatric Psychology, 35(9), 1028–1037.
Cleeland, C. S., Mendoza, T. R., Wang, X. S., Woodruff, J. F., Palos, G. R., Richman, S. P., et al. (2011). Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer center. Journal of Clinical Oncology, 29(21), 2859–2865. PubMedCrossRef
Jones, B. L. (2005). TRAJ: group- based modeling of longitudinal data. http://www.andrew.cmu.edu/user/bjones/. Accessed 22 May 2012.
Lo, Y. T., Mendell, N. R., & Rubin, D. B. (2001). Testing the number of components in a normal mixture. Biometrika, 88(3), 767–778. CrossRef
Rosenthal, D. I., Mendoza, T. R., Chambers, M. S., Burkett, V. S., Garden, A. S., Hessell, A. C., et al. (2008). The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. International Journal of Radiation Oncology Biology Physics, 72(5), 1355–1361. CrossRef
Muthén, B. (2004). Latent variable analysis: growth mixture modeling and related techeniques for longitudinal data. In D. Kaplan (Ed.), The SAGE handbook of quantitative methodology for the social sciences (pp. 345–368). Thousand Oaks, CA: Sage Publications, Inc.
- Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy
Tito R. Mendoza
G. Brandon Gunn
Xin Shelley Wang
David I. Rosenthal
Charles S. Cleeland
- Springer Netherlands